{
    "nct_id": "NCT06024603",
    "official_title": "Individualized Treatments in Adults With Relapsed/Refractory Cancers",
    "inclusion_criteria": "* Participants aged 18 years or older at the time of enrollment on this study of any gender, race, or ethnicity.\n* Patients with suspected or confirmed diagnosis of recurrent or refractory cancer with no curative treatment options.\n* Participants who have undergone at least two lines of previous therapy.\n* Participants who are scheduled for or have recently had biopsy or tumor excised (solid tumors) or bone marrow aspirate (blood cancers) or who have scheduled or recently had paracentesis or thoracentesis performed.\n* Participants willing to have a blood draw or buccal swab done for the purposes of genetic testing.\n* Participants willing to sign informed consent.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Participants who do not have malignant tissue available and accessible.\n* Participants for whom the amount of excised malignant tissue is not sufficient for the ex vivo drug testing and/or genetic profiling.\n* Participants with newly diagnosed tumors and tumors that have high (>90%) cure rate with safe standard therapy.",
    "miscellaneous_criteria": ""
}